Cargando…

Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?

Physiological health must balance immunological responsiveness against foreign pathogens with tolerance toward self-components and commensals. Disruption of this balance causes autoimmune diseases/chronic inflammation, in case of excessive immune responses, and persistent infection/immunodeficiency...

Descripción completa

Detalles Bibliográficos
Autores principales: Povoleri, Giovanni Antonio Maria, Scottà, Cristiano, Nova-Lamperti, Estefania Andrea, John, Susan, Lombardi, Giovanna, Afzali, Behdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694260/
https://www.ncbi.nlm.nih.gov/pubmed/23818888
http://dx.doi.org/10.3389/fimmu.2013.00169
_version_ 1782274840518983680
author Povoleri, Giovanni Antonio Maria
Scottà, Cristiano
Nova-Lamperti, Estefania Andrea
John, Susan
Lombardi, Giovanna
Afzali, Behdad
author_facet Povoleri, Giovanni Antonio Maria
Scottà, Cristiano
Nova-Lamperti, Estefania Andrea
John, Susan
Lombardi, Giovanna
Afzali, Behdad
author_sort Povoleri, Giovanni Antonio Maria
collection PubMed
description Physiological health must balance immunological responsiveness against foreign pathogens with tolerance toward self-components and commensals. Disruption of this balance causes autoimmune diseases/chronic inflammation, in case of excessive immune responses, and persistent infection/immunodeficiency if regulatory components are overactive. This homeostasis occurs at two different levels: at a resting state to prevent autoimmune disease, as autoreactive effector T-cells (Teffs) are only partially deleted in the thymus, and during inflammation to prevent excessive tissue injury, contract the immune response, and enable tissue repair. Adaptive immune cells with regulatory function (“regulatory T-cells”) are essential to control Teffs. Two sets of regulatory T cell are required to achieve the desired control: those emerging de novo from embryonic/neonatal thymus (“thymic” or tTregs), whose function is to control autoreactive Teffs to prevent autoimmune diseases, and those induced in the periphery (“peripheral” or pTregs) to acquire regulatory phenotype in response to pathogens/inflammation. The differentiation mechanisms of these cells determine their commitment to lineage and plasticity toward other phenotypes. tTregs, expressing high levels of IL-2 receptor alpha chain (CD25), and the transcription factor Foxp3, are the most important, since mutations or deletions in these genes cause fatal autoimmune diseases in both mice and men. In the periphery, instead, Foxp3(+) pTregs can be induced from naïve precursors in response to environmental signals. Here, we discuss molecular signatures and induction processes, mechanisms and sites of action, lineage stability, and differentiating characteristics of both Foxp3(+) and Foxp3(−) populations of regulatory T cells, derived from the thymus or induced peripherally. We relate these predicates to programs of cell-based therapy for the treatment of autoimmune diseases and induction of tolerance to transplants.
format Online
Article
Text
id pubmed-3694260
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-36942602013-07-01 Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators? Povoleri, Giovanni Antonio Maria Scottà, Cristiano Nova-Lamperti, Estefania Andrea John, Susan Lombardi, Giovanna Afzali, Behdad Front Immunol Immunology Physiological health must balance immunological responsiveness against foreign pathogens with tolerance toward self-components and commensals. Disruption of this balance causes autoimmune diseases/chronic inflammation, in case of excessive immune responses, and persistent infection/immunodeficiency if regulatory components are overactive. This homeostasis occurs at two different levels: at a resting state to prevent autoimmune disease, as autoreactive effector T-cells (Teffs) are only partially deleted in the thymus, and during inflammation to prevent excessive tissue injury, contract the immune response, and enable tissue repair. Adaptive immune cells with regulatory function (“regulatory T-cells”) are essential to control Teffs. Two sets of regulatory T cell are required to achieve the desired control: those emerging de novo from embryonic/neonatal thymus (“thymic” or tTregs), whose function is to control autoreactive Teffs to prevent autoimmune diseases, and those induced in the periphery (“peripheral” or pTregs) to acquire regulatory phenotype in response to pathogens/inflammation. The differentiation mechanisms of these cells determine their commitment to lineage and plasticity toward other phenotypes. tTregs, expressing high levels of IL-2 receptor alpha chain (CD25), and the transcription factor Foxp3, are the most important, since mutations or deletions in these genes cause fatal autoimmune diseases in both mice and men. In the periphery, instead, Foxp3(+) pTregs can be induced from naïve precursors in response to environmental signals. Here, we discuss molecular signatures and induction processes, mechanisms and sites of action, lineage stability, and differentiating characteristics of both Foxp3(+) and Foxp3(−) populations of regulatory T cells, derived from the thymus or induced peripherally. We relate these predicates to programs of cell-based therapy for the treatment of autoimmune diseases and induction of tolerance to transplants. Frontiers Media S.A. 2013-06-27 /pmc/articles/PMC3694260/ /pubmed/23818888 http://dx.doi.org/10.3389/fimmu.2013.00169 Text en Copyright © 2013 Povoleri, Scottà, Nova-Lamperti, John, Lombardi and Afzali. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Immunology
Povoleri, Giovanni Antonio Maria
Scottà, Cristiano
Nova-Lamperti, Estefania Andrea
John, Susan
Lombardi, Giovanna
Afzali, Behdad
Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
title Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
title_full Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
title_fullStr Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
title_full_unstemmed Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
title_short Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
title_sort thymic versus induced regulatory t cells – who regulates the regulators?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694260/
https://www.ncbi.nlm.nih.gov/pubmed/23818888
http://dx.doi.org/10.3389/fimmu.2013.00169
work_keys_str_mv AT povolerigiovanniantoniomaria thymicversusinducedregulatorytcellswhoregulatestheregulators
AT scottacristiano thymicversusinducedregulatorytcellswhoregulatestheregulators
AT novalampertiestefaniaandrea thymicversusinducedregulatorytcellswhoregulatestheregulators
AT johnsusan thymicversusinducedregulatorytcellswhoregulatestheregulators
AT lombardigiovanna thymicversusinducedregulatorytcellswhoregulatestheregulators
AT afzalibehdad thymicversusinducedregulatorytcellswhoregulatestheregulators